OrbiMed

OrbiMed

OrbiMed

From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will he
Founded
1989
Follow us
26 Aug 2021
$60,000,000
Venture capital (Series B)
08 Jan 2021
$123,000,000
Venture capital (Series D)

Carlyle leads $123m Series D for China's Abbisko

AVCJ
+1
28 Oct 2020

CAR-T Biotech Firm Gracell Completes $100 Million Round – China Money Network

ChinaMoneyNetwork
+1
31 Aug 2020

Erasca Completes $36M Extension of Series B Financing

FinSMEs
+1